Since HRG expression itself correlates with tumourigenicity and metastasis in breast cancer cells lines [39,40], it will be interesting to assess whether the induction of these genes is affected by chemical inhibition of the PI3K pathway, or whether such inhibitors would make clinically useful therapeutics for breast cancer treatment. The gene discussed is HRG; the disease is breast carcinoma.